Clinical Trials Logo
  1. Home
  2. Oncology
  3. NCT04623437
  4. Details
NCT04623437 Clinical Trial

Responsible Side Effects Management in Oncology

Oncology Clinical Trial

— R-SEMO  

Official title:
Comprehensive Antineoplastic Therapy Adverse Events Monitoring and Report

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04623437
Other study ID # 2312201522122016
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2017
Est. completion date September 5, 2017

Study information
Verified date November 2020
Source University Hospital "Sestre Milosrdnice"
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Study of pharmacovigilance in oncology. Monitoring and management of AEs during antineoplastic treatment.

Description:

Monitoring and management of AE's during antineoplastic treatment. Comparison of AE's reported by patient with the ones recognised by the oncologist, and vice versa, during antineoplastic treatment.

Recruitment information / eligibility
Status Completed
Enrollment 267
Est. completion date September 5, 2017
Est. primary completion date September 5, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: all cancer patients receiving systemic antineoplastic treatment, ECOG 0-2 Exclusion Criteria: age <18, >75; other active and severe comorbidities; no solid cancer; IUC patients

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Croatia UHC Sestre milorsdnice Zagreb Croatia, Europe

Sponsors (1)
Lead Sponsor Collaborator
University Hospital "Sestre Milosrdnice"

Country where clinical trial is conducted

Croatia, 

Outcome
Type Measure Description Time frame Safety issue
Primary comparison of perspectives comparison between patient's and oncologist's perspective on severity of AE's during antineoplastic treatment may 2016 until october 2016
See also
  Status Clinical Trial Phase
Completed NCT01439152 - Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Phase 1
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Active, not recruiting NCT06015009 - Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers N/A
Active, not recruiting NCT03298100 - Risk Scoring Model for Endometrial Cancer
Recruiting NCT05055609 - Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors Phase 1
Not yet recruiting NCT04324320 - Psychological Distress in Outpatient Oncological Rehabilitation
Completed NCT00588289 - Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA N/A
Recruiting NCT06222801 - The 1st Tumor CytokinoTherapy Database (TCTD-1)
Recruiting NCT03831633 - Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Phase 4
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Recruiting NCT05712174 - A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer Phase 2
Recruiting NCT03832062 - Value of Analysing Under-utilised Leftover Tissue (VauLT)
Completed NCT03988777 - Magnetic Seed Localisation for Nonpalpable Breast Lesions
Recruiting NCT06031233 - Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie Phase 4
Enrolling by invitation NCT04019119 - Digital Intervention for the Modification of Lifestyles (iGame) N/A
Not yet recruiting NCT05926362 - Capillary-Venous Paired Data Collection
Recruiting NCT05510856 - Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients Phase 4
Recruiting NCT05686213 - ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial Phase 2
Completed NCT04180306 - PEWS Implementation in an LMIC Setting N/A